Kairos Pharma, Ltd.'s total assets for Q1 2026 were $5.74M, a decrease of -12.17% from the previous quarter. KAPA total liabilities were $431.00K for the fiscal quarter, a 116.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.